Pictor and Rako Science bring improved access to COVID-19 antibody testing for New Zealand with technology from Tasso
Rako Science will utilize its national network by collecting blood samples with a device from Tasso, Inc., and undertake testing for COVID-19 antibodies.
- Rako Science will utilize its national network by collecting blood samples with a device from Tasso, Inc., and undertake testing for COVID-19 antibodies.
- In an effort to protect the entire New Zealand population as much as possible, Pictor has partnered with Rako Science and Tasso to improve accessibility.
- Pictor partnered with Rako Science, an Auckland-based high-tech pathology company and U.S.-based Tasso, Inc., the leading provider of convenient, clinical-grade blood collection solutions.
- This test plays to one of our core strengths which is rapid, translational science, said Leon Grice of Rako Science.